Botulinum Toxins, Type ANeuromuscular AgentsBotulinum ToxinsMuscle SpasticityAnti-Dyskinesia AgentsClostridium botulinumInjections, IntramuscularBotulismBlepharospasmBotulinum AntitoxinTorticollisHyperhidrosisSialorrheaCosmetic TechniquesHemifacial SpasmParaparesis, SpasticSkin AgingMuscle Relaxants, CentralHypohidrosisInjectionsCerebral PalsyCryoanesthesiaSpasmHemiplegiaUpper ExtremityNeurotoxinsShiga Toxin 2Treatment OutcomeSweat GlandsPain MeasurementTetanus ToxinFissure in AnoMeige SyndromeClostridium botulinum type AParasympatholyticsClostridium botulinum type EStrokeShiga Toxin 1GaitCholera ToxinRange of Motion, ArticularDouble-Blind MethodDystoniaEsophageal AchalasiaFacial MusclesDystonic DisordersT-2 ToxinQuality-Adjusted Life YearsShiga ToxinsDose-Response Relationship, DrugSweating, GustatoryLethal Dose 50Spinal Cord InjuriesSynaptosomal-Associated Protein 25EnterotoxinsNeuromuscular JunctionBacterial ToxinsFollow-Up StudiesToxins, BiologicalPatient SatisfactionMolecular Sequence DataAntitoxinsOculomotor MusclesCost-Benefit AnalysisUrinary Bladder, OveractiveProspective StudiesEquinus DeformityClostridiumClostridium botulinum type BRejuvenationToxoidsClostridium botulinum type FToxemia